Bill
Ensuring Access to Essential Drugs Act This bill exempts certain brand-name drugs from the Medicare Part D Manufacturer Discount Program. Under the program, drug manufacturers provide discounts to beneficiaries who have incurred costs…
Overview and Timeline are the same for every version. Text and Votes below change with the version you select.
Introduced in House — Mar 5, 2025
This Act may be cited as the “Ensuring Access to Essential Drugs Act”.
Section 1860D–14C(g)(2) of the Social Security Act (42 U.S.C. 1395w–114c(g)(2)) is amended—
(1)
in subparagraph (A), by striking “and” at the end;
(2)
in subparagraph (B), by striking the period and inserting “; and”; and
(3)
by adding at the end the following new subparagraph:
(C)
does not include an orally administered drug—
(i)
for which a new drug application was approved under section 505 of the Federal Food, Drug, and Cosmetic Act; and
(ii)
that has been granted a narrow exception permitting reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program by the Centers for Medicare & Medicaid Services.